Dr. Jamie Lee Steinmetz, MD

Dr. Steinmetz practices at OSF Little Company of Mary Medical Center in Evergreen Park, Illinois, part of OSF HealthCare System.

Dr. Steinmetz's NPI, 1326310830, was assigned on January 30, 2012. Dr. Steinmetz holds Illinois license 036130115.

Dr. Steinmetz's primary practice is OSF Little Company of Mary Medical Center, at 2800 W 95th St, Evergreen Park, IL 60805 in Cook County. The practice phone is (708) 422-6200.

Dr. Steinmetz's primary practice is OSF Little Company of Mary Medical Center in Evergreen Park, Illinois, part of OSF HealthCare System. The medical group on file is Consultants In Clinical Pathology. Dmand AI also links Dr. Steinmetz to 1 more breast imaging center and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Steinmetz practices, 3 sites in all. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Steinmetz's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Steinmetz is licensed in Illinois.

CMS data shows 922 Medicare services from Dr. Steinmetz across 11 procedure codes in 2024, for 300 Medicare patients. Medicare paid $22,898 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 300 Medicare patients who saw Dr. Steinmetz in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Steinmetz's median patient age at 66, with 60% women.

Dr. Steinmetz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 31 general payments to Dr. Steinmetz from 13 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $219.